// App-Quantinova.ai

: Successful Development of an Outpatient Chimeric Antigen Receptor (CAR) T Cell Therapy Program

Researchers

Presenter

  • Azra Borogovac

Principal Investigators

  • Amany R. Keruakous

  • Michelle Bycko

  • Jennifer Holter Chakrabarty

  • Sami Ibrahimi

  • Mohamad O. Khawandanah

  • George B. Selby

  • Carrie Yuen

  • Sarah A. Schmidt

  • Taha Al-Juhaishi

  • Matthew Wieduwilt

  • Adam S. Asch

Medical Centers

  • Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK

  • Marrow and Stem Cell Transplant Program, University of Oklahoma, Oklahoma City, OK

  • Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Diffuse large B-cell lymphoma

  • Acute lymphoblastic leukemia

  • Cytokine release syndrome

  • Mantle cell lymphoma

  • B cell lymphomas

  • Multiple Myeloma

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Coxsackie Virus And Adenovirus Receptor

  • Interleukin 6

  • Twist-related protein 1

Drug/Treatment

  • Axicabtagene ciloleucel

  • tisagenlecleucel-t

  • Dexamethasone

  • Dekpak 13 Day Taperpak

Outcome

  • N/A

Study Design

  • pivotal

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved